Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1947 2
1949 1
1955 1
1958 2
1959 1
1960 2
1962 3
1963 3
1964 2
1965 3
1966 4
1967 5
1968 4
1969 12
1970 10
1971 3
1972 13
1973 12
1974 14
1975 11
1976 17
1977 16
1978 22
1979 24
1980 32
1981 34
1982 24
1983 17
1984 26
1985 45
1986 36
1987 50
1988 63
1989 85
1990 72
1991 90
1992 97
1993 109
1994 136
1995 132
1996 145
1997 158
1998 179
1999 171
2000 203
2001 234
2002 223
2003 257
2004 395
2005 437
2006 539
2007 622
2008 772
2009 884
2010 1004
2011 1175
2012 1318
2013 1369
2014 1505
2015 1629
2016 1723
2017 1870
2018 2014
2019 2157
2020 2434
2021 2758
2022 3190
2023 2962
2024 3299
2025 1484

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34,049 results

Results by year

Filters applied: . Clear all
Page 1
Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis.
Zhang S, Lin H, Wang J, Rui J, Wang T, Cai Z, Huang S, Gao Y, Ma T, Fan R, Dai R, Li Z, Jia Y, Chen Q, He H, Tan J, Zhu S, Gu R, Dong Z, Li M, Xie E, Fu Y, Zheng J, Jiang C, Sun J, Kong W. Zhang S, et al. Among authors: lin h. Nature. 2025 May;641(8062):476-485. doi: 10.1038/s41586-025-08792-8. Epub 2025 Mar 6. Nature. 2025. PMID: 40049228
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: lin hl. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19.
Ying H, Wu X, Jia X, Yang Q, Liu H, Zhao H, Chen Z, Xu M, Wang T, Li M, Zhao Z, Zheng R, Wang S, Lin H, Xu Y, Lu J, Wang W, Ning G, Zheng J, Bi Y. Ying H, et al. Among authors: lin h. EBioMedicine. 2025 Mar;113:105596. doi: 10.1016/j.ebiom.2025.105596. Epub 2025 Feb 10. EBioMedicine. 2025. PMID: 39933264 Free PMC article.
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial.
Kuerer HM, Valero V, Smith BD, Krishnamurthy S, Diego EJ, Johnson HM, Lin H, Shen Y, Lucci A, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Hunt KK, Yang WT, Rauch GM; Exceptional Responders Study Group. Kuerer HM, et al. Among authors: lin h. JAMA Oncol. 2025 May 1;11(5):529-534. doi: 10.1001/jamaoncol.2025.0207. JAMA Oncol. 2025. PMID: 40152443 Clinical Trial.
Synthetic Cells and Molecules in Cellular Immunotherapy.
Lin H, Li C, Zhang W, Wu B, Wang Y, Wang S, Wang D, Li X, Huang H. Lin H, et al. Int J Biol Sci. 2024 May 11;20(8):2833-2859. doi: 10.7150/ijbs.94346. eCollection 2024. Int J Biol Sci. 2024. PMID: 38904025 Free PMC article. Review.
A statistical framework for multi-trait rare variant analysis in large-scale whole-genome sequencing studies.
Li X, Chen H, Selvaraj MS, Van Buren E, Zhou H, Wang Y, Sun R, McCaw ZR, Yu Z, Jiang MZ, DiCorpo D, Gaynor SM, Dey R, Arnett DK, Benjamin EJ, Bis JC, Blangero J, Boerwinkle E, Bowden DW, Brody JA, Cade BE, Carson AP, Carlson JC, Chami N, Chen YI, Curran JE, de Vries PS, Fornage M, Franceschini N, Freedman BI, Gu C, Heard-Costa NL, He J, Hou L, Hung YJ, Irvin MR, Kaplan RC, Kardia SLR, Kelly TN, Konigsberg I, Kooperberg C, Kral BG, Li C, Li Y, Lin H, Liu CT, Loos RJF, Mahaney MC, Martin LW, Mathias RA, Mitchell BD, Montasser ME, Morrison AC, Naseri T, North KE, Palmer ND, Peyser PA, Psaty BM, Redline S, Reiner AP, Rich SS, Sitlani CM, Smith JA, Taylor KD, Tiwari HK, Vasan RS, Viali S, Wang Z, Wessel J, Yanek LR, Yu B; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; Dupuis J, Meigs JB, Auer PL, Raffield LM, Manning AK, Rice KM, Rotter JI, Peloso GM, Natarajan P, Li Z, Liu Z, Lin X. Li X, et al. Among authors: lin h. Nat Comput Sci. 2025 Feb;5(2):125-143. doi: 10.1038/s43588-024-00764-8. Epub 2025 Feb 7. Nat Comput Sci. 2025. PMID: 39920506 Free PMC article.
34,049 results
You have reached the last available page of results. Please see the User Guide for more information.